The future
of care delivered
today.
The largest integrated clinical research site network in Ibero-America - one SOP, one unified CTMS, one governed quality system across 10 countries. Not a marketplace of contracted sites. One network, one oversight model.
Built for global pharmaceutical teams.
MSD
Roche
Regeneron
Amgen
AstraZeneca
Eli Lilly
Pfizer
Bristol Myers Squibb
Sanofi
Novartis
Gilead
Takeda
IQVIA
Built on integration, governance and depth - not headcount.
Not a marketplace of contracted sites. One network, one oversight model - a single SOP, one unified CTMS, and one governed quality system across every country at once.
No subcontracted site networks. No quality gaps between countries. One point of contact for your entire program.
Multi-country trials shouldn't mean multi-country risk.
Contracting individual sites across several countries leaves a sponsor holding several quality systems, several data trails, and the oversight burden ICH E6(R3) now expects them to actively manage. Celerity removes the seams.
- A different SOP, training standard and audit trail at every site
- Quality gaps between countries the sponsor must detect and close
- Disconnected systems - no single source of truth for oversight
- Each contract, submission and timeline negotiated in isolation
- One SOP and one training standard applied at every site
- One governed quality system - no gaps between countries
- One unified CTMS as the single system of record
- One point of contact coordinating submissions in parallel
What a single governed system gives you.
10 countries.
One standard.
One network.
Every Celerity site operates under the same SOP framework, the same training standards, and the same reporting infrastructure. Your monitor visits every country with zero protocol variation surprises.
View full site directory →
centers active
across network
across all sites
managed in-house
A bridge from Ibero-America to the European standard.
Celerity's network is expanding into Europe through Spain, giving sponsors a governed on-ramp to the EMA standard under the same single quality system that runs across Ibero-America. Deployment begins in Málaga through agreements with HM Hospitales, a national hospital group.
High-volume Pacific and Andean enrollment and a European bridge to EMA-standard data - combined under one network and one oversight model. A footprint built on integration, not assembled per study.
Note: Spain is presented as an expansion of the site network and a clinical bridge - not as a CRO service offering.
Built for sponsors who don't accept excuses.
Every process documented.
Every site auditable.
24-hour audit notice accepted at any site. Single source of truth across all 10 countries.
Approval timelines across our network.
Each country has distinct requirements. Our in-house teams navigate them so you can focus on science.
Where we operate.
From feasibility to first patient in.
Streamlined, transparent, and sponsor-managed at every stage.
Submit your protocol.
We respond in 48h.
Our feasibility team will respond within 48 hours with site-level enrollment estimates, investigator profiles, and regulatory timelines across your selected countries.